About Singular Bio
Singular Bio is a company based in San Francisco (United States) founded in 2012 by Hywel Jones was acquired by Invitae in June 2019.. Singular Bio has raised $6.58 million across 2 funding rounds from investors including Invitae and The Vertical Group. Singular Bio operates in a competitive market with competitors including Novogene Corporation, Rejuvenate Bio, Source BioScience, Macrogen and Beikang Medical, among others.
- Headquarter San Francisco, United States
- Founders Hywel Jones
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Singular Bio
Singular Bio has successfully raised a total of $6.58M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $6.58 million completed in February 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series A — $6.6M
- First Round First Round
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2019 | Amount | Series A - Singular Bio | Valuation |
investors |
|
| Jun, 2013 | Amount | Seed - Singular Bio | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Singular Bio
Singular Bio has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Invitae and The Vertical Group. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments in early and late-stage US companies are made.
|
Founded Year | Domain | Location | |
|
Home-based genetic tests for detecting diseases are provided to individuals.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Singular Bio
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Singular Bio
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Singular Bio Comparisons
Competitors of Singular Bio
Singular Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Novogene Corporation, Rejuvenate Bio, Source BioScience, Macrogen and Beikang Medical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Genomic services and solutions with NGS expertise are provided.
|
|
| domain | founded_year | HQ Location |
Gene-editing platform and anti-aging therapy for dogs are developed.
|
|
| domain | founded_year | HQ Location |
Multiple genomic services are provided for analysis and diagnostics.
|
|
| domain | founded_year | HQ Location |
Next-generation sequencing and genomics services are provided globally.
|
|
| domain | founded_year | HQ Location |
NGS-based diagnostic solutions for neonatal screening are developed.
|
|
| domain | founded_year | HQ Location |
Bioinformatics platform for genetic disease analysis is provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Singular Bio
Frequently Asked Questions about Singular Bio
When was Singular Bio founded?
Singular Bio was founded in 2012 and raised its 1st funding round 1 year after it was founded.
Where is Singular Bio located?
Singular Bio is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Who is the current CEO of Singular Bio?
Hywel Jones is the current CEO of Singular Bio. They have also founded this company.
Is Singular Bio a funded company?
Singular Bio is a funded company, having raised a total of $6.58M across 2 funding rounds to date.
What does Singular Bio do?
Singular Bio was founded in 2012 in San Francisco, United States, within the biotechnology sector. A proprietary single molecule detection system is provided, where unique measurements are taken for each molecule through the integration of advanced optics, custom molecular biology, and chemistry. The screening platform is utilized for its user-friendly design, flexibility, and scalable throughput, supporting deployment in testing labs of varying sizes across different locations.
Who are the top competitors of Singular Bio?
Singular Bio's top competitors include Novogene Corporation, Source BioScience and Genewiz.
Who are Singular Bio's investors?
Singular Bio has 2 investors. Key investors include Invitae, and The Vertical Group.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.